Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma

Near Complete Pathologic Response to PD-1 Inhibitor and Radiotherapy in a Patient with Locally Advanced Pancreatic Ductal Adenocarcinoma

Patrick M McCarthy,1 Matthew J Rendo,2 Matthew D Uy,3 Alexandra M Adams,1 Anne E O’Shea,1 Daniel William Nelson,4 Joshua L Fenderson,2 Katherine M Cebe,3 Robert W Krell,1 Guy T Clifton,1 George E Peoples,5 Timothy J Vreeland1 1Department of Surgery, Brooke Army Medical Center, San Antonio,...

Full description

Bibliographic Details
Main Authors: McCarthy PM, Rendo MJ, Uy MD, Adams AM, O'Shea AE, Nelson DW, Fenderson JL, Cebe KM, Krell RW, Clifton GT, Peoples GE, Vreeland TJ
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:OncoTargets and Therapy
Subjects:
pancreatic cancer
pembrolizumab
complete response
pd-l1
locally advanced
immune checkpoint inhibitor
Online Access:https://www.dovepress.com/near-complete-pathologic-response-to-pd-1-inhibitor-and-radiotherapy-i-peer-reviewed-fulltext-article-OTT

Internet

https://www.dovepress.com/near-complete-pathologic-response-to-pd-1-inhibitor-and-radiotherapy-i-peer-reviewed-fulltext-article-OTT

Similar Items